类风湿关节炎与间质性肺病:合并症的作用——英国两个RA初始队列的回顾性分析
该研究基于英国两个连续的多中心前瞻性RA初始队列共2701例患者,中位随访6年,采用三种合并症评估工具分析基线合并症与间质性肺病(ILD)发生的关联。多变量分析显示,年龄、血清阳性、吸烟史及RDCI肺病组分评估的较高肺部合并症负担与ILD诊断相关,而其他合并症评估方法未显示关联。结论认为合并症评估方法影响基线合并症与后续ILD的关联,RDCI可揭示通用工具或简单计数未检测到的关联,基线肺部合并症应加入RA相关ILD的已知风险因素列表。
要点
- RDCI肺病组分评估的肺部合并症负担与ILD诊断相关(aOR 4.59)。
- 年龄、血清阳性、吸烟史与ILD诊断相关(aOR分别为1.03、2.58、1.70)。
- 合并症评估方法影响基线合并症与后续ILD的关联是否显著。
核心结论
- 合并症负担的评估方法影响基线合并症是否与后续ILD发生相关。
- RDCI可揭示通用工具或简单计数未检测到的关联。
- 基线肺部合并症应加入RA相关ILD的已知风险因素列表,并有助于靶向筛查。
研究设计与样本
- 数据来自两个连续的多中心前瞻性RA初始队列,共纳入2701例患者,中位随访6年。
- 合并症负担采用主要合并症计数、风湿病合并症指数(RDCI)和Charlson合并症指数(CCI)评估。
- 采用多变量逻辑回归分析合并症与ILD发生的关联,并校正临床因素。
主要发现
- 多变量分析中,发病年龄(aOR 1.03,95%CI 1.01-1.05)、血清阳性(aOR 2.58,95%CI 1.38-4.81)和曾经吸烟(aOR 1.70,95%CI 1.04-2.79)与ILD诊断相关。
- RDCI肺病组分评估的较高肺部合并症负担与ILD相关(aOR 4.59,95%CI 2.68-7.88),使用整个RDCI指数亦相关(aOR 1.32,95%CI 1.07-1.63)。
- 使用其他合并症评估方法时,关联未持续存在。
临床怎么用
- 在RA患者中应关注基线肺部合并症,将其纳入ILD风险因素评估。
- 可考虑使用RDCI(尤其是肺病组分)评估合并症负担以辅助ILD风险分层。
- 对具有年龄、血清阳性、吸烟史及肺部合并症负担高的RA患者,可考虑靶向筛查ILD。
局限性
- 本研究为回顾性分析,部分ILD病例从死亡证明中识别。
- 合并症与ILD的关联取决于所选评估工具,不同工具结果不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the role of comorbidities measurements in interstitial lung disease (ILD) in patients with RA. METHODS: The data were from two consecutive multicentre, prospective RA inception cohorts, including baseline socio-demographic, clinical, treatment, laboratory and functional features. Comorbidity burden was assessed using a count of major comorbidities, the Rheumatic Disease Comorbidity Index (RDCI) and the Charlson Comorbidity Index (CCI). Associations between comorbidities and the development of ILD were explored, adjusted for clinical factors using multivariable logistic regression analyses. RESULTS: The data from 2701 patients were included, and the median follow-up time was 6 years. In total, 101 patients (3.7%) were diagnosed with ILD. Twelve (0.44%) had the diagnosis at baseline, 46 were diagnosed during follow-up, and 43 were identified from death certificates. In multivariable analyses, age at onset [adjusted odds ratio (aOR) 1.03, 95% CI 1.01-1.05], seropositivity (aOR 2.58, 95% CI 1.38-4.81) and ever smoking (aOR 1.70, 95% CI 1.04-2.79) were associated with ILD diagnosis. Higher lung comorbidity burden measured using the lung disease component of the RDCI (aOR 4.59, 95% CI 2.68-7.88) was associated, as was using the entire index (aOR 1.32, 95% CI 1.07-1.63). The association did not remain when assessing comorbidity with alternative measures. CONCLUSION: The method chosen to assess the comorbidity burden affected whether baseline comorbidity was associated with subsequent ILD development. This study demonstrates that a specific Rheumatic Disease Comorbidity Index reveals associations not detected by generic tools or simple counts. Baseline lung comorbidities should be added to the known list of risk factors for ILD and aid targeted screening in the context of RA.
引用
- Dacheva R, Busby A, Kiely P, et al. Rheumatoid arthritis and interstitial lung disease: the role of comorbidities-a retrospective analysis of two RA inception cohorts in the UK. Rheumatology (Oxford). 2026. PMID: 41693018. doi:10.1093/rheumatology/keag089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。